Abstract: Cyathostomins are the most prevalent parasitic pathogens of equids worldwide. These nematodes have been controlled using broad-spectrum anthelmintics; however, cyathostomin resistance to each anthelmintic class has been reported and populations insensitive to more than one class are relatively commonplace. The faecal egg count reduction test (FECRT) is considered the most suitable method for screening anthelmintic sensitivity in horses, but is subject to variation and is relatively time-consuming to perform. Here, we describe a larval migration inhibition test (LMIT) to assess ivermectin (IVM) sensitivity in cyathostomin populations. This test measures the paralysing effect of IVM on the ability of third stage larvae (L3) to migrate through a pore mesh. When L3 from a single faecal sample were examined on multiple occasions, variation in migration was observed: this was associated with the length of time that the L3 had been stored before testing but the association was not significant. Half maximal effective concentration (EC50) values were then obtained for cyathostomin L3 from six populations of horses or donkeys that showed varying sensitivity to IVM in previous FECRTs. Larvae from populations indicated as IVM resistant by FECRT displayed significantly higher EC50 values in the LMIT than L3 from populations classified as IVM sensitive or L3 from populations that had not been previously exposed to IVM or had limited prior exposure. The analysis also showed that EC50 values obtained using L3 from animals in which IVM faecal egg count reduction (FECR) levels had been recorded as <95% were significantly higher than EC50 values obtained using L3 from animals for which FECR was measured as >95%. For one of the populations, time that had elapsed since IVM administration had an effect on the EC50 value obtained, with a longer time since treatment associated with lower EC50 values. These results indicate that the LMIT has value in discriminating IVM sensitivity amongst cyathostomin populations, but several factors were identified that need to be taken into account when executing the test and interpreting the derived data.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article focuses on the development and analysis of a larval migration inhibition test (LMIT) that measures sensitivity of cyathostomin populations, a common parasitic pathogen in horses, to the veterinary drug Ivermectin (IVM).
Understanding Cyathostomins and IVM
Cyathostomins are a type of nematode, or roundworm, and are the most prevalent parasitic pathogens found in equids (horses, donkeys, and related animals) across the globe. They have been traditionally controlled using anthelmintics, a type of drug designed to combat worm infestations.
Ivermectin is a common broad-spectrum anthelmintic. However, resistance against multiple types of these drugs, including IVM, has been reported amongst cyathostomin populations. Therefore, identifying sensitivity or resistance to these drugs is critical in determining effective treatment plans for infected equids.
Traditional Detection: FECRT
The most common method used to detect anthelmintic sensitivity has been the faecal egg count reduction test (FECRT). This test measures changes in the number of eggs found in faeces following treatment to assess the effectiveness of the drug.
While the FECRT is widely used, it has been subject to significant variation and it is relatively time-consuming to execute, making it less efficient and reliable as a testing method.
Development and Assessment of LMIT
To overcome the limitations of FECRT, the researchers developed a Larval Migration Inhibition Test (LMIT) with the objective to assess Ivermectin sensitivity in cyathostomin populations.
The LMIT measures the paralysing effect of Ivermectin on the ability of the third-stage larvae (L3) of cyathostomins to migrate through a pore mesh. Decreased mobility suggests greater sensitivity to IVM, while increased mobility implies resistance.
Initial testing revealed that variations in larval migration were associated with the duration the L3 had been stored prior to testing. However, the association was not significant enough to affect the overall test results.
Comparison of LMIT and FECRT
The researchers then obtained half maximal effective concentration (EC50) values for cyathostomin L3 from six different populations that displayed varying sensitivity to IVM based on previous FECRTs.
Populations deemed IVM-resistant by FECRT showed significantly higher EC50 values in the LMIT than those classified as IVM-sensitive or those with limited previous exposure to IVM.
The timing of IVM treatment also appeared to affect EC50 values. For one population, a longer time since treatment was associated with lower EC50 values. As such, further consideration of this factor may be required during testing.
Conclusion
The study’s results suggest that the LMIT provides valuable data on IVM sensitivity amongst different cyathostomin populations.
The test does have various factors that need to be considered for its successful application and accurate interpretation of results, however, it presents significant potential for more efficient and reliable assessment of anthelmintic resistance.
Cite This Article
APA
McArthur CL, Handel IG, Robinson A, Hodgkinson JE, Bronsvoort BM, Burden F, Kaplan RM, Matthews JB.
(2015).
Development of the larval migration inhibition test for comparative analysis of ivermectin sensitivity in cyathostomin populations.
Vet Parasitol, 212(3-4), 292-298.
https://doi.org/10.1016/j.vetpar.2015.06.019